Clinically Oriented Subtyping of Chronic Insomnia of Childhood

Oliviero Bruni1, Stefania Sette1, Marco Angriman2

  • 1Department of Developmental and Social Psychology, Sapienza University of Rome, Rome, Italy.

Insights

Pediatric insomnia presents in three distinct phenotypes, identified through clinical, personal, and familial data. Recognizing these profiles can improve the assessment and treatment of sleep disturbances in children.

Area of Science:

  • Pediatric Sleep Medicine
  • Child Psychology
  • Genetics

Background:

  • Pediatric insomnia is a common issue, often resistant to standard treatments.
  • Understanding distinct insomnia profiles is crucial for effective intervention.

Purpose of the Study:

  • To identify and characterize different phenotypes of pediatric insomnia.
  • To analyze the clinical presentations, personal, and familial factors associated with each phenotype.

Main Methods:

  • Latent class analysis was employed on data from 338 children with insomnia.
  • Structured parent interviews assessed insomnia characteristics and family sleep history.
  • ANOVA and chi-squared tests compared differences between identified profiles.

Main Results:

  • Three distinct pediatric insomnia phenotypes were identified.
  • Class 1 (17%) exhibited difficulty falling asleep with restlessness.
  • Class 2 (21%) presented with early morning awakenings and mood disorders in family history.
  • Class 3 (62%) showed frequent nocturnal awakenings and difficulty falling asleep, with allergies/intolerances in family history.

Conclusions:

  • The study confirms three distinct phenotypes of pediatric insomnia.
  • Phenotype identification aids in optimizing assessment and treatment strategies.
  • Personal and familial data are key in differentiating insomnia profiles.
Abstract

Related Concept Videos

Insomnia01:27

Insomnia

Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
503
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
683
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
683
Location and Orientation of the Heart01:13

Location and Orientation of the Heart

The human heart, despite its modest size and weight, is an organ of remarkable strength and endurance. Roughly the size of a fist, the heart weighs between 250 and 350 grams and is nestled within the mediastinum, the medial cavity of the thorax. It extends obliquely for about 12 to 14 cm, resting on the superior surface of the diaphragm. The heart is positioned anterior to the vertebral column and posterior to the sternum, with two-thirds of its mass lying to the left of the midsternal line.
10.8K
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
3.0K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.9K